Key statistics
SmartText not available for this item.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 172.00 |
Low | 172.00 |
Bid | -- |
Offer | -- |
Previous close | 172.00 |
Average volume | -- |
---|---|
Shares outstanding | 136.64m |
Free float | 121.00m |
P/E (TTM) | -- |
Market cap | 1.06bn USD |
EPS (TTM) | -3.58 USD |
Data delayed at least 20 minutes, as of Sep 13 2023 12:30 BST.
More ▼
- Vir Biotechnology to Participate in the H.C. Wainwright 4th Annual Hepatitis B Virus (HBV) Conference
- Vir Biotechnology Announces Multiple Abstracts Highlighting New Chronic Hepatitis B and Hepatitis Delta Data Accepted for Presentation at AASLD’s The Liver Meeting® 2023
- Vir Biotechnology to Provide Business Update and Report Third Quarter 2023 Financial Results on November 2, 2023
- Vir Biotechnology Awarded BARDA Funding to Support Development of Antibody Platform Technologies for Global Infectious Disease Threats